Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,773.50
Bid: 1,772.00
Ask: 1,772.50
Change: 12.50 (0.71%)
Spread: 0.50 (0.028%)
Open: 1,770.00
High: 1,776.00
Low: 1,766.00
Prev. Close: 1,761.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Stocks in holding pattern ahead of key data

Mon, 28th Jul 2014 09:24

- GSK break-up possibly on the cards- RyanAir reports doubling of first quarter profits- Aberdeen Asset Management sees slight drop in AuMtechMARK 2,794.05 -0.19%FTSE 100 6,800.81 +0.14%FTSE 250 15,661.43 -0.19%The Footsie was trading little changed early on in the session, ahead of what was set to be a busy week, particularly in the latter half. The top tier index was standing 5.29 points higher than Friday's close of 6,791.55 as of 09:11. While geopolitical tensions continued to be in focus, traders were also looking to the many corporate releases and economic data set to be released throughout the week, not least Friday's monthly non-farm payrolls numbers Stateside.Alpari UK Analyst Craig Erlam said that with little out from Europe in the early part of the week, "the US is likely to be the biggest driver of most of the major markets this week". He continued: "This is particularly true in the second half of the week when we'll have a barrage of massive economic indicators, almost 100 S&P 500 companies reporting second quarter earnings and a Federal Open Market Committee decision to cap everything off. "Do not underestimate how big an impact that final few days of the week could have on the markets. We've all been looking for that thing that brings volatility back to the markets, well this could well be it."The build up to this could result in some degree of greater risk aversion, he further explained, although the number of companies releasing results will help to limit this. Data that is due to be released later on today includes the US July Markit services and composite Purchasing Mangers' Index (PMI) figures, alongside June pending home sales. Back in the UK, and in this morning's company news, Reckitt Benkiser said that it expects market conditions to remain challenging in the second half of the year, particularly in the US and certain emerging markets, but that it was still on track to achieve its full year total revenue growth target of 4-5%. The household goods group also announced that it is planning to hive off its drug arm into a separate UK-listed company. A breakup of GlaxoSmithKline is a possibility as a result of a sweeping overhaul of the group, according to the Chief Executive of the pharmaceuticals giant, the Financial Times reports. Budget airline Ryanair more than doubled its first quarter profit and said it was raising annual profit expectations, but warned of second-half pressure on fares from rival price-cutting. Ryanair said first quarter net profit rose 152% to €197m versus the same time a year ago due partly to a strong Easter, but cautioned that it compared with no holiday in the same period last time.Aberdeen Asset Management reported a pick-up in business in Asia and emerging markets, but revealed a slight fall in assets under management. Assets under management at June 30th totalled £322.5bn, down 0.6% on the £324.5m at the end of March 2014.Randgold Resources said it was focusing on its Tongon gold mine in Côte d'Ivoire where it is "continuing to make headway" in its efforts to overcome the technical issues that have affected its performance. Chief Executive Mark Bristow admitted this year's planned ramp-up in production had not been achieved due to the need to expand the flotation circuit and the mechanical failure of the recently installed Vibrocone crushers, intended to improve the recovery and throughput rate. National Grid reported a continued "solid operational and financial performance" between April 1st and July 27th, with the UK delivering operational efficiencies and progress with its investment programme, while the US saw a good operational performance.FTSE 100 - RisersReckitt Benckiser Group (RB.) 5,220.00p +2.96%Travis Perkins (TPK) 1,647.00p +1.29%Diageo (DGE) 1,820.00p +1.25%British Sky Broadcasting Group (BSY) 884.00p +1.09%Fresnillo (FRES) 930.00p +1.03%easyJet (EZJ) 1,345.00p +0.98%Unilever (ULVR) 2,644.00p +0.92%Morrison (Wm) Supermarkets (MRW) 172.50p +0.88%Imperial Tobacco Group (IMT) 2,627.00p +0.84%SABMiller (SAB) 3,361.50p +0.72%FTSE 100 - FallersAberdeen Asset Management (ADN) 442.20p -3.74%Royal Bank of Scotland Group (RBS) 358.30p -1.62%Hargreaves Lansdown (HL.) 1,058.00p -0.94%Pearson (PSON) 1,124.00p -0.71%BT Group (BT.A) 380.30p -0.70%Land Securities Group (LAND) 1,044.00p -0.67%ARM Holdings (ARM) 856.50p -0.64%Persimmon (PSN) 1,272.00p -0.62%Ashtead Group (AHT) 942.00p -0.53%St James's Place (STJ) 785.50p -0.51%FTSE 250 - RisersEvraz (EVR) 100.50p +2.45%Lonmin (LMI) 246.40p +2.24%esure Group (ESUR) 257.30p +1.94%African Barrick Gold (ABG) 264.50p +1.81%Pace (PIC) 374.50p +1.66%Diploma (DPLM) 639.00p +1.35%Rank Group (RNK) 161.00p +1.19%Domino Printing Sciences (DNO) 634.00p +1.12%Debenhams (DEB) 64.80p +1.09%AO World (AO.) 214.40p +1.08%FTSE 250 - FallersAlent (ALNT) 338.10p -4.19%Exova Group (EXO) 225.60p -4.00%Just Eat (JE.) 213.20p -2.65%PayPoint (PAY) 1,040.00p -2.62%Fidessa Group (FDSA) 2,077.00p -2.35%Spectris (SXS) 1,889.00p -2.33%Brit (BRIT) 242.10p -1.98%Betfair Group (BET) 1,017.00p -1.74%Riverstone Energy Limited (RSE) 905.00p -1.63%Renishaw (RSW) 1,869.00p -1.58%AB
More News
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.